Time-Dependent Oxidative Alterations in Plasma and Lung Tissue after Meconium Aspiration in a Rabbit Model.

inflammation meconium aspiration oxidative damage surfactant inactivation

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
25 Dec 2022
Historique:
received: 24 11 2022
revised: 19 12 2022
accepted: 22 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

Aspirated meconium into a newborn's airways induces the transcription of pro-oxidative mediators that cooperate in the pathogenesis of inflammatory changes and may negatively affect the commonly used exogenous surfactant therapy. However, inflammation is not treated at present, nor is the time dependence of oxidative damage known. The aim of our study was to describe the time course of oxidative stress marker production during meconium aspiration syndrome (MAS) and its relationship to leukocyte infiltration. New Zealand rabbits were instilled with saline or meconium suspension and ventilated for 5.5 h. Respiratory parameters were recorded and blood samples were taken before meconium application and in time intervals of 15 and 30 min, 1.0, 1.5, 3.5 and 5.5 h after application to evaluate oxidative markers and differential leukocytes count. Meconium aspiration led to a worsening of respiratory parameters and a decrease in leukocytes in the first 15 min. Changes in leukocytes were correlated both with nitrotyrosine (3NT) levels and thiobarbituric acid reactive substance (TBARS) levels, with the latter also related to changes in neutrophil count. The production of 3NT and TBARS increased in 1.5 and 3.5 h, respectively, in different ways, suggesting more than one source of oxidative agents and a potential risk of exogenous surfactant inactivation in a short time. We observed that MAS triggered neutrophil migration to the alveolar space and activation, as shown by the increased expression of pro-inflammatory cytokines and generation of indicators of oxidative damage to proteins and lipids during the time period when iNOS and NO metabolites were released.

Identifiants

pubmed: 36670899
pii: antiox12010037
doi: 10.3390/antiox12010037
pmc: PMC9854924
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : VEGA
ID : 1/0004/21
Organisme : APVV
ID : 17-0250

Références

Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Mol Med. 2011 Mar-Apr;17(3-4):293-307
pubmed: 21046059
Children (Basel). 2021 Mar 23;8(3):
pubmed: 33806734
Biophys J. 2011 Feb 2;100(3):646-655
pubmed: 21281579
Am J Perinatol. 2002 Jul;19(5):279-84
pubmed: 12152147
Am J Respir Cell Mol Biol. 2012 May;46(5):566-72
pubmed: 22323365
J Appl Physiol Respir Environ Exerc Physiol. 1977 Aug;43(2):198-203
pubmed: 578145
Mol Immunol. 2010 Mar;47(6):1226-34
pubmed: 20092898
Am J Obstet Gynecol. 1989 Nov;161(5):1106-10
pubmed: 2589429
Respir Med. 2016 Oct;119:23-28
pubmed: 27692143
Inflammation. 2021 Aug;44(4):1507-1517
pubmed: 33751359
Lab Invest. 2002 Apr;82(4):425-41
pubmed: 11950900
Cell Mol Life Sci. 2012 Jul;69(14):2373-85
pubmed: 22581364
Pediatr Res. 2016 Apr;79(4):514-21
pubmed: 26679157
Adv Exp Med Biol. 2016;934:63-75
pubmed: 27283193
Am J Physiol Lung Cell Mol Physiol. 2001 Nov;281(5):L1037-50
pubmed: 11597894
Pediatr Res. 2001 Jun;49(6):820-5
pubmed: 11385144
Acta Pharmacol Sin. 2005 Sep;26(9):1123-9
pubmed: 16115381
Mediators Inflamm. 2010;2010:
pubmed: 20706658
Intensive Care Med. 2020 Dec;46(12):2252-2264
pubmed: 33169217
Eur J Pharmacol. 2022 Jul 5;926:175047
pubmed: 35609679
Mediators Inflamm. 2010;2010:682879
pubmed: 20592757
Pediatr Res. 2003 Oct;54(4):491-5
pubmed: 12840156
Eur J Pediatr. 2011 Dec;170(12):1495-505
pubmed: 21465122
Biochem Biophys Res Commun. 2005 Dec 9;338(1):668-76
pubmed: 16126168
Int J Clin Exp Med. 2015 May 15;8(5):6804-12
pubmed: 26221218
J Perinatol. 2016 May;36 Suppl 1:S49-54
pubmed: 27109092
Exp Lung Res. 2018 Feb;44(1):40-50
pubmed: 29324051
Pediatr Pulmonol. 2006 Jan;41(1):55-60
pubmed: 16229002
J Mol Neurosci. 2016 Aug;59(4):544-53
pubmed: 27339772
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:173-81
pubmed: 19218641
J Matern Fetal Neonatal Med. 2004 Aug;16(2):125-30
pubmed: 15512724
Respir Care. 2009 Sep;54(9):1203-8
pubmed: 19712497
J Physiol Pharmacol. 2016 Feb;67(1):57-65
pubmed: 27010895
Physiol Res. 2016 Dec 22;65(Suppl 5):S653-S662
pubmed: 28006947
Cell Physiol Biochem. 2016;40(6):1603-1612
pubmed: 28006762
Part Fibre Toxicol. 2010 May 21;7:13
pubmed: 20492675
Eur Surg Res. 2006;38(1):35-41
pubmed: 16490992
J Biol Chem. 2000 Jul 14;275(28):21130-9
pubmed: 10801793
Physiol Res. 2013;62(Suppl 1):S191-200
pubmed: 24329699
Am J Respir Cell Mol Biol. 2018 Jul;59(1):1-2
pubmed: 29957050
J Immunol. 2004 Sep 15;173(6):3589-93
pubmed: 15356101
J Physiol Pharmacol. 2012 Apr;63(2):179-86
pubmed: 22653905
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Sep;32(9):1238-41
pubmed: 22985554
Eur Respir J. 1997 Sep;10(9):1983-8
pubmed: 9311489
Am J Obstet Gynecol. 1991 Feb;164(2):477-81
pubmed: 1992687
Pharmacol Rep. 2012;64(3):511-20
pubmed: 22814004
Physiol Res. 2012;61(2):145-51
pubmed: 22292725
Am J Respir Cell Mol Biol. 2014 Mar;50(3):614-25
pubmed: 24134589
Free Radic Biol Med. 2007 Jan 15;42(2):153-64
pubmed: 17189821
Redox Biol. 2021 Jan;38:101796
pubmed: 33246293
Biophys J. 2006 Apr 15;90(8):2808-21
pubmed: 16443649
Pediatr Res. 2005 Jun;57(6):813-8
pubmed: 15774832
Expert Rev Respir Med. 2019 Feb;13(2):193-203
pubmed: 30571925
Chest. 1998 Dec;114(6):1653-9
pubmed: 9872202
J Clin Invest. 2003 Oct;112(8):1234-43
pubmed: 14561708
Pediatr Res. 2004 Feb;55(2):326-33
pubmed: 14605247
Physiol Res. 2013;62(2):139-43
pubmed: 23234411
PLoS One. 2015 Mar 18;10(3):e0119918
pubmed: 25786132
J Clin Invest. 2003 Apr;111(7):1011-20
pubmed: 12671050
Bioengineered. 2021 Dec;12(1):2616-2626
pubmed: 34499011
Crit Care. 2010;14(2):209
pubmed: 20236452
Life Sci. 2021 Aug 15;279:119662
pubmed: 34081989
Pediatr Crit Care Med. 2013 Nov;14(9):876-83
pubmed: 23863822
Am J Respir Cell Mol Biol. 2009 May;40(5):519-35
pubmed: 18978300
Interdiscip Toxicol. 2011 Jun;4(2):63-8
pubmed: 21753901
Respir Res. 2020 Nov 4;21(1):293
pubmed: 33148285
Physiol Res. 2012;61(4):425-30
pubmed: 22670696
J Immunol. 2007 May 15;178(10):6017-22
pubmed: 17475823
J Immunol. 2001 Jan 15;166(2):1169-77
pubmed: 11145698
Results Probl Cell Differ. 2017;62:181-207
pubmed: 28455710
Mol Cell. 2007 Jun 8;26(5):675-87
pubmed: 17560373
Am J Physiol Lung Cell Mol Physiol. 2004 Jul;287(1):L143-52
pubmed: 15047567

Auteurs

Petra Kosutova (P)

Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.

Nikolett Nemcova (N)

Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.

Maros Kolomaznik (M)

Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.

Daniela Mokra (D)

Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.

Andrea Calkovska (A)

Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.

Pavol Mikolka (P)

Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.

Classifications MeSH